4.9
肺水腫とは、肺の間質腔および肺胞腔に液体が蓄積し、ガス交換や酸素供給を妨げる現象です。心因性または非心因性の場合がありますが、どちらも酸素供給と肺の遵守を低下させます。
心因性浮腫は、通常、心筋梗塞、心不全、または弁膜疾患による左心室機能障害による肺毛細血管の静水圧の上昇によって引き起こさ…
心因性肺水腫は通常、心不全で見られる左心室機能障害から始まります。
これにより肺毛細血管内の静水圧が上昇し、毛細血管から間質空間への純粋な液体移動を引き起こし、肺胞が水浸しになります。
一方、非心源性浮腫では、主なメカニズムは毛細血管透過性の増加であり、急性呼吸困難症候群や有害吸入の発生によって引き起こされることが多いです。
タンパク質豊富な液体が肺胞に漏れ出し、浸透圧的に追加の水分を取り込みます。
いずれの場合も、肺胞液は界面活性剤を乱し、表面張力を高め、肺の服従性を低下させ、呼吸を困難にします。ガス交換は拡散距離の増加と換気・灌流の不一致により低下します。
治療を怠ると、肺水腫は呼吸不全に進行し、重度の呼吸困難や息切れが特徴です。低酸素症、つまり血中酸素不足;そして高炭酸血症、すなわち二酸化炭素濃度の上昇です。
View the full transcript and gain access to JoVE Core videos
Q1: What causes cardiogenic pulmonary edema?
Cardiogenic pulmonary edema results from left ventricular dysfunction, commonly seen in heart failure, myocardial infarction, or valvular disease. This dysfunction raises hydrostatic pressure in pulmonary capillaries, disrupting the balance between hydrostatic and oncotic forces. Fluid moves from capillaries into interstitial and alveolar spaces, impairing gas exchange and causing hypoxemia and dyspnea.
Q2: How does noncardiogenic pulmonary edema develop differently from cardiogenic edema?
Noncardiogenic edema occurs with normal hydrostatic pressure but increased capillary permeability due to injury or inflammation of the alveolar-capillary membrane. Conditions like acute respiratory distress syndrome or toxic inhalation damage endothelial barriers, allowing protein-rich fluid to leak into alveoli. This high-protein fluid draws in additional water osmotically, worsening edema without cardiac dysfunction.
Q3: How does pulmonary edema affect lung compliance and breathing?
Fluid accumulation in alveoli disrupts surfactant, increases surface tension, and reduces lung compliance, making alveolar expansion difficult. Increased diffusion distance and ventilation-perfusion mismatch further impair gas exchange. These changes force the respiratory muscles to work harder, increasing breathing effort and contributing to dyspnea and reduced oxygenation.
Q4: What are the severe complications of untreated pulmonary edema?
Untreated pulmonary edema can progress to acute respiratory failure, characterized by severe dyspnea, hypoxemia (low blood oxygen), and hypercapnia (elevated carbon dioxide). Fluid-filled alveoli cannot participate in gas exchange, leading to refractory hypoxemia. Prompt identification of the underlying cause is critical, as cardiogenic and noncardiogenic edema require distinct treatment strategies to restore adequate gas exchange.
Q5: Why does protein-rich fluid worsen noncardiogenic pulmonary edema?
In noncardiogenic edema, damaged alveolar-capillary membranes allow protein-rich fluid to leak into alveoli. The high protein concentration creates an osmotic gradient that draws additional water into the alveolar space, amplifying fluid accumulation. This mechanism differs from cardiogenic edema, where hydrostatic pressure drives fluid movement without significant protein leakage.
Q6: How does pulmonary edema impair gas exchange?
Fluid-filled alveoli cannot participate in gas exchange, increasing the diffusion distance between blood and air. Ventilation-perfusion mismatch occurs when fluid blocks ventilation to perfused areas. Together, these changes reduce oxygen uptake and carbon dioxide elimination, causing hypoxemia and hypercapnia that characterize respiratory failure if severe.
Q7: Why is distinguishing between cardiogenic and noncardiogenic edema important for treatment?
Cardiogenic and noncardiogenic pulmonary edema require distinct treatment strategies because they result from different pathophysiologic mechanisms. Cardiogenic edema stems from left ventricular dysfunction and elevated hydrostatic pressure, while noncardiogenic edema involves increased capillary permeability. Patients with respiratory complications may also benefit from understanding chronic obstructive pulmonary disease clinical manifestations to recognize overlapping symptoms.